Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2011-06-28
2011-06-28
Bunner, Bridget E (Department: 1649)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C514S008500, C514S008600, C514S008700
Reexamination Certificate
active
07968679
ABSTRACT:
Complexes of IGF-I and IGFBP-3 with new levels of purity are provided. Chromatographic techniques have been developed that remove contaminants, such as mass and charge variants of IGFBP-3. The new techniques enable the production of high-quality pharmaceutical compositions comprising IGF-I/IGFBP-3 complexes.
REFERENCES:
patent: 5200509 (1993-04-01), Spencer et al.
patent: 5670341 (1997-09-01), Spencer et al.
patent: 5681818 (1997-10-01), Spencer et al.
patent: 5723441 (1998-03-01), Higley et al.
patent: 5789547 (1998-08-01), Sommer et al.
patent: 5948757 (1999-09-01), Sommer et al.
patent: 6015786 (2000-01-01), Mascarenhas et al.
patent: 6017885 (2000-01-01), Basi et al.
patent: 6025332 (2000-02-01), Mascarenhas
patent: 6025368 (2000-02-01), Mascarenhas et al.
patent: 6417330 (2002-07-01), Mascarenhas et al.
patent: 6436897 (2002-08-01), Danko et al.
patent: 6514937 (2003-02-01), Mascarenhas
patent: 6518238 (2003-02-01), Mascarenhas
patent: 2002/0004478 (2002-01-01), Danko et al.
patent: 2003/0087806 (2003-05-01), Danko et al.
patent: 199 51 824 (2001-05-01), None
patent: WO 95/03817 (1995-02-01), None
patent: WO 99/32620 (1999-07-01), None
patent: WO 02/24219 (2002-03-01), None
Yoshimura et al., J Immunol. 1989; 142: 1956-1962.
Patten et al., (Dev Biol (Basel). 2003; 112: 81-97.
Chi et al., Pharmaceutical Res. 2003; 20: 1325-1336.
Adams et al., “Pharmacokinetics and Bioavailability of rhIGF-I/IGFBP-3 in the Rat and Monkey,”Progress. Growth Factor Res. 6(2-4):347-56 (1995).
Blum et al., “Plasma IGFBP-3 Levels as Clinical Indicators,”Modem Concepts of Insulin-like Growth Factors, pp. 381-393, 1991.
Geoghegan et al,. “Spontaneous α-N-6-phospyhogluconoylation of a “His Tag” inEscherichi coli: The Cause of Extra Mass of 258 or 178 Da in Fusion Proteins,”Analytical Biochemistry267(1) 169-84, 1999.
Kelley Glen L.
Sleevi Mark C.
Borgeest Christina
Bunner Bridget E
Greenberg & Traurig, LLP
Insmed Incorporated
LandOfFree
Purified rhIGF-I/rhIGFBP-3 complexes and their method of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purified rhIGF-I/rhIGFBP-3 complexes and their method of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purified rhIGF-I/rhIGFBP-3 complexes and their method of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2680705